Tags:
Bought CALL options in $BTAI following overreactions about miscommunication.
Drugs already approved under different forms of administration and company plan to apply for NDA end of the year.
The dip was bough up, so I believe that if market condition will stay the same, the stock will keep trending higher.
Possible buyout target since the company has cash only till 2025, so a big pharma might swoop in to get the company before product hit the market.
This is my opinion only, do your DD
Execution detail:
Date/time | Symbol | Qty | Price | Position |
---|---|---|---|---|
2023-07-19 15:19:52 | AUG18 23 12.50 CALL | 3 | $1.550 | 3 |
2023-08-18 15:59:59 | AUG18 23 12.50 CALL | -3 | $0.0000 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!